Cargando…

Efficacy of low-dose spironolactone on top of angiotensin receptor blockade in patients with glomerulonephritis

BACKGROUND: Previous studies have shown that aldosterone antagonists have a proteinuria-lowering effect in patients with proteinuria and progressive proteinuric disease not adequately controlled by the use of angiotensin receptor blockers (ARBs). Aldosterone antagonists, in combination with ARBs, mi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Byung Chul, Lee, Min Sung, Moon, Jong Joo, Choi, Soo Jeong, Kim, Jin Kuk, Hwang, Seung Duk, Park, Moo Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Nephrology 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147182/ https://www.ncbi.nlm.nih.gov/pubmed/30254850 http://dx.doi.org/10.23876/j.krcp.2018.37.3.257

Ejemplares similares

Idiopathic or iatrogenic membranous glomerulonephritis? A case of spironolactone-induced membranous glomerulonephritis
por: Inaba, Akimichi, et al.
Publicado: (2011)

Comparison of spironolactone and trichlormethiazide as add‐on therapy to renin–angiotensin blockade for reduction of albuminuria in diabetic patients
por: Hase, Michiyo, et al.
Publicado: (2013)

Effect of spironolactone combined with angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers on chronic glomerular disease
por: WANG, WEISONG, et al.
Publicado: (2013)

Evaluation of early left-sided cardiac reverse remodeling under combined therapy of sacubitril-valsartan and spironolactone compared with angiotensin-converting enzyme inhibitors and spironolactone
por: Sacharczuk, Wioletta, et al.
Publicado: (2023)

Clinic and Home Blood Pressure Lowering Effect of an Angiotensin Receptor Blocker, Fimasartan, in Postmenopausal Women with Hypertension
por: Kim, Song-Yi, et al.
Publicado: (2016)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
por: Velat, Ivan, et al.
Publicado: (2020)

Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan
por: Makhlough, Atieh, et al.
Publicado: (2014)

Organoprotective Effects of Spironolactone on Top of Ramipril Therapy in a Mouse Model for Alport Syndrome
por: Rubel, Diana, et al.
Publicado: (2021)

Use of low-dose sulodexide in IgA nephropathy patients on renin–angiotensin system blockades
por: Yang, Byeong Yun, et al.
Publicado: (2012)

Therapeutic Efficacy of Spironolactone for Central Serous Chorioretinopathy
por: Han, Jae Yong, et al.
Publicado: (2022)

The impact of a dose of the angiotensin receptor blocker valsartan on post‐myocardial infarction ventricular remodelling
por: Park, Kyungil, et al.
Publicado: (2018)

Reanalysis of membranoproliferative glomerulonephritis patients according to the new classification: a multicenter study()
por: Woo, Sung Ae, et al.
Publicado: (2014)

No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial
por: Ferreira, João Pedro, et al.
Publicado: (2021)

Effect of spironolactone and benazepril on furosemide‐induced diuresis and renin‐angiotensin‐aldosterone system activation in normal dogs
por: Adin, Darcy, et al.
Publicado: (2021)

Myostatin/Appendicular Skeletal Muscle Mass (ASM) Ratio, Not Myostatin, Is Associated with Low Handgrip Strength in Community-Dwelling Older Women
por: Choi, Soo Jeong, et al.
Publicado: (2021)

Impact of initial blood flow on outcomes of vascular access in hemodialysis patients
por: Choi, Soo Jeong, et al.
Publicado: (2012)

Involvement of the Intrarenal Renin-Angiotensin System in Experimental Models of Glomerulonephritis
por: Urushihara, Maki, et al.
Publicado: (2012)

The Beneficial Effect of Renin-Angiotensin-Aldosterone System Blockade in Marfan Syndrome Patients after Aortic Root Replacement
por: Lee, Seung-Jun, et al.
Publicado: (2016)

Spironolactone-Induced Unilateral Gynecomastia
por: Veeregowda, Sahana Hadihalli, et al.
Publicado: (2018)

The Impact of Renin-Angiotensin System Blockade on Renal Outcomes and Mortality in Pre-Dialysis Patients with Advanced Chronic Kidney Disease
por: Oh, Yun Jung, et al.
Publicado: (2017)

Gastric Syphilis and Membranous Glomerulonephritis
por: Roh, Min, et al.
Publicado: (2015)

The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study
por: Na, Soo Jin, et al.
Publicado: (2022)

Minimal Change Disease Is Associated with Mitochondrial Injury and STING Pathway Activation
por: Yu, Byung Chul, et al.
Publicado: (2022)

Prediction of Heart Function and Volume Status in End-Stage Kidney Disease Patients through N-Terminal Pro-Brain Natriuretic Peptide †
por: Lee, Kyung Ho, et al.
Publicado: (2022)

Angiotensin-receptor blockade in acute stroke
por: Rajendran, Srijithesh P.
Publicado: (2011)

Ferritin as a predictor of decline in residual renal function in peritoneal dialysis patients
por: Hur, Soon Mi, et al.
Publicado: (2014)

Corrigendum: The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study
por: Na, Soo Jin, et al.
Publicado: (2022)

Ischemic monomelic neuropathy: a rare complication after vascular access formation
por: Han, Ji Soo, et al.
Publicado: (2013)

A Case of Post-Streptococcal Glomerulonephritis with Diffuse Alveolar Hemorrhage
por: Sung, Hye-Young, et al.
Publicado: (2007)

Renin-Angiotensin System Blockade in Acute Myocardial Infarction: Is There a Winner?
por: Lee, Hak Seung, et al.
Publicado: (2020)

Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade
por: Perez-Gomez, Maria Vanessa, et al.
Publicado: (2015)

Effect of spironolactone on pain responses in mice
por: Abdel-Salam, Omar M.E., et al.
Publicado: (2010)

Spironolactone in cardiovascular disease: an expanding universe?
por: Funder, John W.
Publicado: (2017)

Imatinib and spironolactone suppress hepcidin expression
por: Mleczko-Sanecka, Katarzyna, et al.
Publicado: (2017)

Furosemide/spironolactone: Hypotension: case report
Publicado: (2022)

Can patiromer allow for intensified renin–angiotensin–aldosterone system blockade with losartan and spironolactone leading to decreased albuminuria in patients with chronic kidney disease, albuminuria and hyperkalaemia? An open-label randomised controlled trial: MorphCKD
por: Mårup, Frederik Husum, et al.
Publicado: (2022)

Fibrillary glomerulonephritis combined with chronic inflammatory demyelinating polyneuropathy
por: Sung, Woo Kyung, et al.
Publicado: (2015)

Intrarenal renin–angiotensin system activation and macrophage infiltrations in pediatric chronic glomerulonephritis
por: Hattori, Tomoki, et al.
Publicado: (2023)

A case of membranoproliferative glomerulonephritis associated with metastatic colon cancer
por: Ryu, Jung-Hwa, et al.
Publicado: (2013)

Membranoproliferative glomerulonephritis presenting as arthropathy and cardiac valvulopathy in hypocomplementemic urticarial vasculitis: a case report
por: Park, Chuiyoung, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qp9kep4equ0mtd5s47ik4d2q2d